Axogen, Inc. — Director's Dealing 2024

Jun 11, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2024-06-06

Reporting Person: THOMAS PAUL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-06	Common Stock	A	10653	—	Acquired	20148	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-06	Employee Stock Option (right to purchase)	$7.04	A	18248	Acquired	2034-06-06	Common Stock (18248)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F2: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 6, 2025, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.